THE BIOEQUIVALENCE STUDY OF THE DRUG “PROSTANIK” (FERULEN) PRODUCED BY LLC “NIKA PHARM”

Main Article Content

Tukhtasheva V.F.

Abstract

The active substance of the "prastanic" (ferulene) medicinal drug capsules produced by LLC "NIKA PHARM" is not differ from ferulene tablets produced by ICPS AS RUz The acute toxicity parameters of both compared drugs with the orally administered are not differ and are classified as low toxic substances; The "prastanic" produced by LLC "NIKA PHARM" and ferulen produced by the ICPS AS RUz equally reduces the mass of androgen-dependent organs, which indicates the bioequivalence of the compared drugs.

Downloads

Download data is not yet available.

Article Details

How to Cite
Tukhtasheva V.F. (2021). THE BIOEQUIVALENCE STUDY OF THE DRUG “PROSTANIK” (FERULEN) PRODUCED BY LLC “NIKA PHARM” . International Journal of Innovations in Engineering Research and Technology, 1-4. https://repo.ijiert.org/index.php/ijiert/article/view/2201
Section
Articles

How to Cite

Tukhtasheva V.F. (2021). THE BIOEQUIVALENCE STUDY OF THE DRUG “PROSTANIK” (FERULEN) PRODUCED BY LLC “NIKA PHARM” . International Journal of Innovations in Engineering Research and Technology, 1-4. https://repo.ijiert.org/index.php/ijiert/article/view/2201